Sun Pharmaceutical Industries Ltd - 524715 - Compliance Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Please find enclosed Compliance Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Sun Pharmaceutical Industries Ltd - 524715 - Compliance Certificate Under Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Period October 1, 2020 To March 31, 2021
Please find enclosed Compliance Certificate under Regulation 7 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the period October 1, 2020 to March 31, 2021 SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
We refer to our disclosure, dated 1st April, 2021, under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 informing interalia that DigiHealth Technologies LLP, (the wholly owned entity of our Indian wholly owned subsidiary's investee entity i.e. ABCD Technologies LLP (to be renamed as IndoHealth Services LLP)), has agreed to acquire 100% ownership interest in Pharmarack Technologies Private Limited in tranches. Further to the above, we wish to inform you that the above-referred entity, DigiHealth Technologies LLP has completed on 5th April, 2021 the acquisition of 91.8% of shareholding in Pharmarack by purchase of shares from multiple shareholders in various lots. This is for your information and dissemination. Sun Pharmaceutical Industries Ltd - 524715 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2015
Buy Sun Pharmaceutical Industries: target of Rs 700: Sharekhan
Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 700 in its research report dated April 01, 2021. SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
We would like to inform you that DigiHealth Technologies LLP, the wholly owned entity of our Indian wholly owned subsidiary's investee entity i.e. ABCD Technologies LLP (to be renamed as IndoHealth Services LLP), has agreed to acquire 100% ownership interest in Pharmarack Technologies Private Limited in tranches. The details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Circular No. CIR/CFO/CMD/4/2015 dated 9th September, 2015 are given in Annexure 1 to this letter. We request you to kindly take this in your record and disseminate. Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
We would like to inform you that our wholly owned Indian subsidiary's investee entity i.e. ABCD Technologies LLP (to be renamed as IndoHealth Services LLP) has through its wholly-owned entity DigiHealth Technologies LLP, acquired 66.02% ownership interest in AIOCD Pharmasofttech Awacs Private Limited ('AWACS') though a combination of (i) direct purchase of 50% ownership interest in AWACS and (ii) indirect purchase of 16.02% ownership interest in AWACS through acquisition of 32.04% shareholding interest in Trikaal Mediinfotech Private Limited. It is also agreed to acquire the balance stake subject to fulfilment of certain terms and conditions. The details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Circular No. CIR/CFO/CMD/4/2015 dated 9th September, 2015 are given in Annexure 1 to this letter. We request you to kindly take this in your record and disseminate. SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
In furtherance to our intimation to the stock exchanges on 25th March 2021, that one of the wholly owned Indian subsidiary of Sun Pharmaceutical Industries Limited has subscribed to partnership interest to the extent of 20% in ABCD Technologies LLP (to be renamed as IndoHealth Services LLP), we hereby intimate that post admission of 3 new partners on 30th March 2021, in ABCD Technologies LLP, the partnership interest of our wholly owned Indian subsidiary in ABCD Technologies LLP now stands revised at 12.5% entitling 12.5% share of profit/ loss and voting rights. This is for your information and dissemination. Sun Pharmaceutical Industries Ltd - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 31, 2021 for Raksha Sudhir Valia SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 31, 2021 for Shanghvi Finance Pvt Ltd